Kesimpta and Nausea and vomiting - a phase IV clinical study of FDA data
Summary:
Nausea and vomiting is found among people who take Kesimpta, especially for people who are female, 40-49 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Kesimpta and have Nausea and vomiting. It is created by eHealthMe based on reports of 11,734 people who have side effects when taking Kesimpta from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
11,734 people reported to have side effects when taking Kesimpta.
Among them, 366 people (3.12%) have Nausea and vomiting.
What is Kesimpta?
Kesimpta has active ingredients of ofatumumab. eHealthMe is studying from 11,739 Kesimpta users for its effectiveness, alternative drugs and more.
What is Nausea and vomiting?
Nausea and vomiting is found to be associated with 4,619 drugs and 5,414 conditions by eHealthMe.
Number of Kesimpta and Nausea and vomiting reports submitted per year:
Time on Kesimpta when people have Nausea and vomiting *:
Gender of people who have Nausea and vomiting when taking Kesimpta*:
Age of people who have Nausea and vomiting when taking Kesimpta *:
Common drugs people take besides Kesimpta *:
Common side effects people have besides Nausea and vomiting *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Kesimpta and have Nausea and vomiting?
Check whether Nausea and vomiting is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Nausea and vomiting and when was it recovered:
Expand to all the drugs that have ingredients of ofatumumab:
Alternative drugs to, pros and cons of Kesimpta:
- Kesimpta (11,739 reports)
Common Kesimpta side effects:
- Fatigue (feeling of tiredness): 2,400 reports
- Headache (pain in head): 2,381 reports
- Chills (felling of cold): 2,083 reports
- Fever: 1,815 reports
- Pain: 1,645 reports
- Weakness: 868 reports
- Dizziness: 581 reports
- Indigestion: 366 reports
Browse all side effects of Kesimpta:
a b c d e f g h i j k l m n o p q r s t u v w x y zNausea and vomiting treatments and more:
- Nausea and vomiting (460,731 reports)
COVID vaccines that are related to Nausea and vomiting:
- Nausea and vomiting in Moderna COVID Vaccine
- Nausea and vomiting in Pfizer BioNTech Covid Vaccine
- Nausea and vomiting in Johnson and Johnson Covid Vaccine
Common drugs associated with Nausea and vomiting:
- Prednisone: 21,089 reports
- Metformin: 17,857 reports
- Methotrexate: 17,472 reports
- Aspirin: 17,188 reports
- Humira: 15,798 reports
- Omeprazole: 14,246 reports
- Lisinopril: 11,060 reports
- Ibuprofen: 10,601 reports
- Pantoprazole: 10,539 reports
- Enbrel: 10,295 reports
All the drugs that are associated with Nausea and vomiting:
- Nausea and vomiting (4,619 drugs)
Common conditions associated with Nausea and vomiting:
- Rheumatoid arthritis: 19,306 reports
- High blood pressure: 17,714 reports
- Pain: 17,500 reports
- Multiple sclerosis: 16,606 reports
- Type 2 diabetes: 12,509 reports
All the conditions that are associated with Nausea and vomiting:
- Nausea and vomiting (5,414 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ofatumumab (the active ingredients of Kesimpta) and Kesimpta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Gout in Allopurinol, how severe and when it was recovered? - 3 seconds ago
- Diphenhydramine Hydrochloride vs. Triazolam - 9 seconds ago
- Diovan vs. Fosinopril Sodium And Hydrochlorothiazide - 11 seconds ago
- Doxil vs. Prednisone - 17 seconds ago
- Diphenhydramine Hydrochloride vs. Magnesium - 20 seconds ago
- Divalproex Sodium vs. Primidone - 32 seconds ago
- Gleevec and Adcirca drug interaction - 37 seconds ago
- Doxycycline and Prevacid 24 Hr drug interaction - 48 seconds ago
- Dolophine Hydrochloride vs. Maxalt - 49 seconds ago
- Dolophine Hydrochloride vs. Promethazine Hydrochloride - 53 seconds ago